
Sino Biopharmaceutical
(OTC) SBHMY
Sino Biopharmaceutical Financials at a Glance
Market Cap
$12.77B
Revenue (TTM)
$30.57B
Net Income (TTM)
$3.87B
EPS (TTM)
$0.35
P/E Ratio
40.25
Dividend
$0.23
Beta (Volatility)
0.06 (Low)
Dividend
$0.23
Beta (Volatility)
0.06 (Low)
Price
$14.29
Volume
36
Open
$14.29
Price
$14.29
Volume
36
Open
$14.29
Previous Close
$14.29
Daily Range
$14.29 - $14.29
52-Week Range
$9.48 - $20.16
Dividend
$0.23
Beta (Volatility)
0.06 (Low)
Price
$14.29
Volume
36
Open
$14.29
Previous Close
$14.29
Daily Range
$14.29 - $14.29
52-Week Range
$9.48 - $20.16
SBHMY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sino Biopharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
21,435
CEO
S Y Tse
Website
www.sinobiopharm.comHeadquarters
Wan Chai, HK
SBHMY Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
22%
Net Income Margin
7%
Return on Equity
7%
Return on Capital
14%
Return on Assets
3%
Earnings Yield
2.48%
Dividend Yield
1.61%
Payout Ratio
0.00%
Stock Overview
Market Cap
$12.77B
Shares Outstanding
893.84M
Volume
36
Avg. Volume
11.266
Financials (TTM)
Gross Profit
$25.41B
Operating Income
$6.63B
EBITDA
$7.78B
Operating Cash Flow
$9.29B
Capital Expenditure
$1.70B
Free Cash Flow
$7.59B
Cash & ST Invst.
$22.56B
Total Debt
$16.08B
Sino Biopharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.79B
+10.7%
Gross Profit
$7.25B
+11.2%
Gross Margin
82.47%
N/A
Market Cap
$12.77B
N/A
Market Cap/Employee
$523.75K
N/A
Employees
24,379
N/A
Net Income
$1.69B
+12.3%
EBITDA
$1.98B
+0.1%
Quarterly Fundamentals
Net Cash
$6.89B
+43.2%
Accounts Receivable
$7.87B
+58.4%
Inventory
$2.26B
-4.9%
Long Term Debt
$7.65B
+267.8%
Short Term Debt
$8.42B
+9.3%
Return on Assets
3.08%
N/A
Return on Invested Capital
13.69%
N/A
Free Cash Flow
$0.00
-100.0%
Operating Cash Flow
$0.00
-100.0%